Saturday 17 October 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
46.91
0.84
−1.76%
Follow PACS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | 7 | 8 | 6 |
| 21.90% | 22.96% | 27.11% | 27.92% | ||
| 3.33% | 3.54% | 4.37% | 4.82% | ||
ROIC |
23.15% | 17.52% | 21.93% | 21.42% | |
Return on Tangible Assets |
15.90% | 15.09% | 18.71% | 20.63% | |
Average Days of Receivables |
49.34 | 48.45 | 49.27 | 47.60 | |
Free Cash Flow per Share |
2.51 | 1.92 | 2.43 | 2.89 | |
Free Cash Flow |
393.31 | 299.57 | 381.55 | 456.53 | |
Capital Expenditures |
(78.89) | (104.65) | (108.77) | (116.72) | |
| Other line items | |||||
Cash ROIC |
26.47% | 19.99% | 24.10% | 29.92% | |
Accounts Receivable Turnover |
7.79 | 7.46 | 7.37 | 7.85 | |
Accounts Payable Turnover |
24.47 | 24.55 | 24.05 | 27.82 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
17.02 | 15.56 | 14.46 | 12.68 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.35) | (0.33) | (0.31) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.61% | 7.85% | 7.89% | 7.97% | |
Share Based Compensation of Revenue |
0.99% | 1.02% | 1.15% | 1.34% | |
Interest Coverage |
9.86 | 10.92 | 13.68 | 13.88 | |
Operating CF/Net income |
2.79 | 2.11 | 2.01 | 2.13 | |
Depreciation/Fixed assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
(1.40) | (1.78) | (1.69) | (1.64) | |
Revenue per Share |
32.82 | 33.86 | 34.58 | 35.11 | |
Operating CF per Share |
3.02 | 2.59 | 3.12 | 3.63 | |
Capex per Share |
(0.50) | (0.67) | (0.69) | (0.74) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates